INS and metabolic dysfunction-associated steatotic liver disease: Consequently, metabolic and structural alterations in skeletal muscle can disrupt insulin signaling, promote chronic low-grade inflammation, and increase oxidative stress, all of which are closely associated with the pathogenesis of MASLD [38,39].